BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastroenterol. Jun 28, 2026; 32(24): 118709
Published online Jun 28, 2026. doi: 10.3748/wjg.118709
Table 3 Adjustment models
Model 1
Model 2
Model 3
OR
95%CI
P value
OR
95%CI
P value
OR
95%CI
P value
HBV DNA (< 20) (IU/mL)ReferenceReferenceReferenceReferenceReferenceReferenceReferenceReferenceReference
HBV DNA (20-2000) (IU/mL)2.5661.236-5.3280.0112.6691.274-5.7090.0102.8791.331-6.3760.008
HBV DNA (> 2000) (IU/mL)2.9821.288-6.9090.0112.9871.278-7.0970.0123.6101.438-9.3250.007
TACE2.2451.188-4.2440.0132.1801.137-4.2210.0192.3211.170-4.6630.017
Child-Pugh stage0.4090.191-0.8750.0210.4040.180-0.8510.0210.3520.121-0.9430.044


Write to the Help Desk